HK1162954A1 - A method for screening for a substance having an action of proliferating natural killer cells - Google Patents

A method for screening for a substance having an action of proliferating natural killer cells

Info

Publication number
HK1162954A1
HK1162954A1 HK12103648.6A HK12103648A HK1162954A1 HK 1162954 A1 HK1162954 A1 HK 1162954A1 HK 12103648 A HK12103648 A HK 12103648A HK 1162954 A1 HK1162954 A1 HK 1162954A1
Authority
HK
Hong Kong
Prior art keywords
screening
substance
action
natural killer
killer cells
Prior art date
Application number
HK12103648.6A
Other languages
English (en)
Chinese (zh)
Inventor
Tetsuya Kuhara
Takehito Itoh
Original Assignee
Morinaga Milk Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morinaga Milk Industry Co Ltd filed Critical Morinaga Milk Industry Co Ltd
Publication of HK1162954A1 publication Critical patent/HK1162954A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/18—Togaviridae; Flaviviridae
    • C07K14/19—Rubella virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
HK12103648.6A 2004-09-15 2007-11-15 A method for screening for a substance having an action of proliferating natural killer cells HK1162954A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004268041 2004-09-15

Publications (1)

Publication Number Publication Date
HK1162954A1 true HK1162954A1 (en) 2012-09-07

Family

ID=36059930

Family Applications (2)

Application Number Title Priority Date Filing Date
HK12103648.6A HK1162954A1 (en) 2004-09-15 2007-11-15 A method for screening for a substance having an action of proliferating natural killer cells
HK07112502.9A HK1103987A1 (en) 2004-09-15 2007-11-15 Propagation agent and propagation method for natural killer cell

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK07112502.9A HK1103987A1 (en) 2004-09-15 2007-11-15 Propagation agent and propagation method for natural killer cell

Country Status (10)

Country Link
US (3) US20070116675A1 (ko)
EP (2) EP2402034B1 (ko)
JP (2) JP3970916B2 (ko)
KR (2) KR101059724B1 (ko)
CN (2) CN1897973B (ko)
AU (1) AU2005256118B8 (ko)
CA (1) CA2544155C (ko)
HK (2) HK1162954A1 (ko)
NZ (1) NZ546174A (ko)
WO (1) WO2006030675A1 (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3970916B2 (ja) 2004-09-15 2007-09-05 森永乳業株式会社 ナチュラルキラー細胞の増殖剤及び増殖方法
CN107779433A (zh) * 2016-08-30 2018-03-09 天津市康婷生物工程有限公司 便捷的刺激nk细胞增殖和分化的饲养层制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001503430A (ja) 1996-11-05 2001-03-13 ウイスコンシン アラムナイ リサーチ フオンデーシヨン ナチュラルキラーリンパ球の機能を高める動物の治療方法
AU6307698A (en) 1997-02-03 1998-08-25 Pharming Bv Useful properties of human lactoferrin and variants thereof
JP3619853B2 (ja) 1999-11-26 2005-02-16 独立行政法人理化学研究所 ナチュラルキラー細胞の増殖方法
WO2002047612A2 (en) * 2000-10-27 2002-06-20 Mannatech, Inc. Dietary supplement compositions
JP3970916B2 (ja) 2004-09-15 2007-09-05 森永乳業株式会社 ナチュラルキラー細胞の増殖剤及び増殖方法

Also Published As

Publication number Publication date
US7629316B2 (en) 2009-12-08
KR101059724B1 (ko) 2011-08-26
CN1897973B (zh) 2011-11-23
HK1103987A1 (en) 2008-01-04
US20080287365A1 (en) 2008-11-20
KR20060056415A (ko) 2006-05-24
US20080295188A1 (en) 2008-11-27
AU2005256118A8 (en) 2008-12-11
EP2402034A1 (en) 2012-01-04
EP1790355A1 (en) 2007-05-30
CA2544155C (en) 2012-10-16
WO2006030675A1 (ja) 2006-03-23
NZ546174A (en) 2009-05-31
US20070116675A1 (en) 2007-05-24
JPWO2006030675A1 (ja) 2008-05-15
KR100835877B1 (ko) 2008-06-09
AU2005256118A1 (en) 2006-04-27
AU2005256118B2 (en) 2007-07-19
JP3970916B2 (ja) 2007-09-05
CA2544155A1 (en) 2006-03-23
EP1790355B1 (en) 2012-12-12
AU2005256118B8 (en) 2008-12-11
EP1790355A4 (en) 2009-07-29
JP2007125038A (ja) 2007-05-24
US7628976B2 (en) 2009-12-08
EP2402034B1 (en) 2014-04-16
JP4537413B2 (ja) 2010-09-01
KR20070059216A (ko) 2007-06-11
CN1897973A (zh) 2007-01-17
CN101658678A (zh) 2010-03-03

Similar Documents

Publication Publication Date Title
EP1734112A4 (en) PROCESS FOR PROLIFERATING PLURIPOTENT STEM CELLS
EP1846288A4 (en) METHOD AND DEVICE FOR THE APPLICATION OF SEISMOGRAPHS ON THE SEA BASE
EP1947170A4 (en) STEM CELL DETECTION MATERIAL AND SEPARATION METHOD
GB2437689B (en) Culture and screening methods
IS7992A (is) Dýralaus frumuræktunar aðferð
IL178158A0 (en) Method for augmenting b cell depletion
GB2433598B (en) Amplitude preserving prestack migration method
EP1894235A4 (en) METHOD FOR PRODUCING AN ELECTRODE
EP1796116A4 (en) ELECTRODE MATERIAL AND METHOD FOR THE PRODUCTION THEREOF
EP1743945A4 (en) SCREENING METHOD
EP1931985A4 (en) METHODS OF SCREENING IMMUNO-ADJUVANTS AND VACCINES COMPRISING ANTI-MICROTUBULE IMMUNO-ADJUVANTS
EP1746157A4 (en) PROCESS FOR PLASMA CELL PROGRAMMING
EP1721971A4 (en) SCREENING PROCESS
HK1162954A1 (en) A method for screening for a substance having an action of proliferating natural killer cells
GB0408854D0 (en) Separating method
IL179199A (en) Method of screening for modulators of wrn
SG112083A1 (en) Method for screening autoantigen
GB0318296D0 (en) A method of screening a sample
EP1807889A4 (en) PROCESS FOR PRODUCING ELECTRODE MATERIAL
EP1828474A4 (en) CRIBLE AND METHOD OF PULP SCREENING
GB0513631D0 (en) Electrode and method for making electrode
EP1743944A4 (en) NEW SCREENING PROCEDURE
EP1783489A4 (en) METHOD FOR SEPARATING SMALL HEPATOCYTES USING SPECIFIC ANTIBODY
ZA200607192B (en) Amylin family peptides and methods for making and using them
EP1783208A4 (en) METHOD FOR PRODUCING A NERVENZELLE

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170907